Neurologix's appointments are Inspired
This article was originally published in Scrip
Neurologix, a biotech developing gene therapies for disorders of the brain and central nervous system, has appointed Adrian Adams and Andrew Koven, both former employees of Inspire Pharmaceuticals. Mr Adams takes the role of chairman and CEO, and Mr Koven joins as president and chief administrative officer. Mr Adams most recently served as president and CEO of Inspire, where he led the company through a strategic acquisition by Merck & Co for $430 million. Mr Koven was most recently Inspire's executive vice-president and chief administrative and legal officer.